Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Current Topics in Microbiology and Immunology|August 2, 2011
Ricin vaccine developmentJoan E Smallshaw, Ellen S VitettaVaccine|January 16, 2010
A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicityJoan E Smallshaw, Ellen S VitettaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
A comparison of the in vitro and in vivo activities of IgG and F(ab')2 fragments of a mixture of three monoclonal anti-Her-2 antibodiesCamelia I Spiridon, Sarah Guinn, Ellen S VitettaPlos One|December 14, 2016
The Role of Regulatory B Cell-Like Malignant Cells and Treg Cells in the Mouse Model of BCL1 Tumor DormancyAndrew BitMansour, Laurentiu M Pop, Ellen S VitettaClinical and Vaccine Immunology : CVI|August 24, 2012
Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccineEllen S Vitetta, Joan E Smallshaw, John SchindlerImmunological Reviews|March 28, 2008
Engineering therapeutic monoclonal antibodiesXiao-yun Liu, Laurentiu M Pop, Ellen S VitettaVaccine|September 19, 2007
RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosolJoan E Smallshaw, James A Richardson, Ellen S VitettaInternational Journal of Cancer|August 30, 2008
The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell linesKimberly J Brooks, Elaine J Coleman, Ellen S VitettaJournal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 13, 2012
Pancreatic ductal adenocarcinoma: a review of immunologic aspectsMegan B Wachsmann, Laurentiu M Pop, Ellen S VitettaInternational Immunopharmacology|May 26, 2005
The generation of immunotoxins using chimeric anti-CD22 antibodies containing mutations which alter their serum half-lifeLaurentiu M Pop, Xiaoyun Liu, Victor Ghetie, et al.Pageof 6